Evidence map›Paper›PMID 30987271›Full record

ArticleCancers2019

Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives.

Muhammad Altaf, Naike Casagrande, Elena Mariotto, Nadeem Baig, Abdel-Nasser Kawde, Giuseppe Corona, Roberto Larcher, Cinzia Borghese, Claudia Pavan, Adam A Seliman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Muhammad AltafDepartment of Chemistry, GC University, Lahore 54000, Pakistan. muhammad.altaf@gmail.com.
Naike CasagrandeMolecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. naike.casagrande@libero.it.
Elena MariottoMolecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. mariottoelena@gmail.com.ORCID 0000-0002-3960-8561
Nadeem BaigDepartment of Chemistry, King Fahd University of Petroleum and Minerals, Dhahran 31261, Saudi Arabia. nadeembaig@kfupm.edu.sa.
Abdel-Nasser KawdeDepartment of Chemistry, King Fahd University of Petroleum and Minerals, Dhahran 31261, Saudi Arabia. akawde@kfupm.edu.sa.
Giuseppe CoronaImmunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. giuseppe.corona@cro.it.ORCID 0000-0003-3619-7709
Roberto LarcherCenter for Technological Transfer, Edmund Mach Foundation, 38010 Trento, Italy. roberto.larcher@fmach.it.
Cinzia BorgheseMolecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. cpborghese@cro.it.
Claudia PavanMolecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. c.pavan@outlook.com.
Adam A SelimanLab Technical Support Office (LTSO), King Fahd University of Petroleum and Minerals, Dhahran 31261, Saudi Arabia. adamchemi@gmail.com.
Donatella AldinucciMolecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. daldinucci@cro.it.ORCID 0000-0002-4548-3566
Anvarhusein A IsabDepartment of Chemistry, King Fahd University of Petroleum and Minerals, Dhahran 31261, Saudi Arabia. aisab@kfupm.edu.sa.
Centro di Riferimento Oncologico · ITKing Fahd University of Petroleum and Minerals · SAFondazione Edmund Mach · ITGovernment College University, Lahore · PK

Funding

Associazione Italiana per la Ricerca sul Cancro IG 15844King Fahd University of Petroleum and Minerals IN171005
6 · The paper itself

Abstract

We synthesized eight new bipyridine and bipyrimidine gold (III) dithiocarbamate-containing complexes (

Indexed as

anticancer therapycisplatin resistancedoxorubicin resistancegold (III) complexesprostate cancer

Identifiers

PMID30987271
PMCPMC6521029
OpenAlexW2926062523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.